Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Prince

Showing results (371-380 of 396) with videos related to

Pageof 40
Sort By:
JAMA Otolaryngology-- Head & Neck Surgery|November 2, 2013
High-risk human papillomavirus detection in oropharyngeal, nasopharyngeal, and oral cavity cancers: comparison of multiple methodsHeather M Walline, Chris Komarck, Jonathan B McHugh, et al.
Head & Neck|March 17, 2012
Head and neck squamous cell carcinoma in pregnant womenAnna M Eliassen, Samantha J Hauff, Alice L Tang, et al.
Head & Neck|April 13, 2022
Randomized trial of laryngeal organ preservation evaluating two cycles of induction chemotherapy with platinum, docetaxel, and a novel Bcl-xL inhibitorPaul L Swiecicki, Emily Bellile, Keith Casper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2016
E6 and E7 Antibody Levels Are Potential Biomarkers of Recurrence in Patients with Advanced-Stage Human Papillomavirus-Positive Oropharyngeal Squamous Cell CarcinomaMatthew E Spector, Assuntina G Sacco, Emily Bellile, et al.
Oral Oncology|June 30, 2024
Utility of bioselection with neoadjuvant chemotherapy for organ preservation in patients with T4 laryngeal cancerWilliam J Benjamin, Allen L Feng, Molly Heft Neal, et al.
International Journal of Radiation Oncology, Biology, Physics|October 18, 2007
Response to therapy and outcomes in oropharyngeal cancer are associated with biomarkers including human papillomavirus, epidermal growth factor receptor, gender, and smokingBhavna Kumar, Kitrina G Cordell, Julia S Lee, et al.
Clinical and Translational Radiation Oncology|January 13, 2022
Imaging response assessment for predicting outcomes after bioselection chemotherapy in larynx cancer: A secondary analysis of two prospective trialsLaila A Gharzai, Julia Pakela, Elizabeth M Jaworski, et al.
Head & Neck|February 26, 2017
Integration of high-risk human papillomavirus into cellular cancer-related genes in head and neck cancer cell linesHeather M Walline, Christine M Goudsmit, Jonathan B McHugh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2008
EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancerBhavna Kumar, Kitrina G Cordell, Julia S Lee, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|March 21, 2020
Predictors of survival in patients undergoing oropharyngeal surgery for cancer recurrence after radiation therapyMolly E Heft Neal, Julia Brennan, Catherine T Haring, et al.
Pageof 40

Showing results (371-380 of 396) with videos related to

Sort By:
Pageof 40
JAMA Otolaryngology-- Head & Neck Surgery|November 2, 2013
High-risk human papillomavirus detection in oropharyngeal, nasopharyngeal, and oral cavity cancers: comparison of multiple methodsHeather M Walline, Chris Komarck, Jonathan B McHugh, et al.
Head & Neck|March 17, 2012
Head and neck squamous cell carcinoma in pregnant womenAnna M Eliassen, Samantha J Hauff, Alice L Tang, et al.
Head & Neck|April 13, 2022
Randomized trial of laryngeal organ preservation evaluating two cycles of induction chemotherapy with platinum, docetaxel, and a novel Bcl-xL inhibitorPaul L Swiecicki, Emily Bellile, Keith Casper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2016
E6 and E7 Antibody Levels Are Potential Biomarkers of Recurrence in Patients with Advanced-Stage Human Papillomavirus-Positive Oropharyngeal Squamous Cell CarcinomaMatthew E Spector, Assuntina G Sacco, Emily Bellile, et al.
Oral Oncology|June 30, 2024
Utility of bioselection with neoadjuvant chemotherapy for organ preservation in patients with T4 laryngeal cancerWilliam J Benjamin, Allen L Feng, Molly Heft Neal, et al.
International Journal of Radiation Oncology, Biology, Physics|October 18, 2007
Response to therapy and outcomes in oropharyngeal cancer are associated with biomarkers including human papillomavirus, epidermal growth factor receptor, gender, and smokingBhavna Kumar, Kitrina G Cordell, Julia S Lee, et al.
Clinical and Translational Radiation Oncology|January 13, 2022
Imaging response assessment for predicting outcomes after bioselection chemotherapy in larynx cancer: A secondary analysis of two prospective trialsLaila A Gharzai, Julia Pakela, Elizabeth M Jaworski, et al.
Head & Neck|February 26, 2017
Integration of high-risk human papillomavirus into cellular cancer-related genes in head and neck cancer cell linesHeather M Walline, Christine M Goudsmit, Jonathan B McHugh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2008
EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancerBhavna Kumar, Kitrina G Cordell, Julia S Lee, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|March 21, 2020
Predictors of survival in patients undergoing oropharyngeal surgery for cancer recurrence after radiation therapyMolly E Heft Neal, Julia Brennan, Catherine T Haring, et al.
Pageof 40